PF-Atlas › Drugs › azithromycin

azithromycin

Idiopathic Pulmonary Fibrosis

Clinical trials
6
Developer
Insel Gruppe AG, University Hospital Bern

Overview

azithromycin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 6 tracked IPF clinical trials.

azithromycin clinical trials

NCT02173145 (Not specified)NCT01270074 (Phase 3)NCT05842681 (Not specified)NCT02960503 (Phase 1)NCT02003911 (Phase 4)NCT02803944 (Not specified)

Explore related

All trialsResearch
Medical disclaimer. This page summarizes research about azithromycin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.